212 related articles for article (PubMed ID: 23833051)
41. Pathology of the pleura: what the pulmonologists need to know.
Cagle PT; Allen TC
Respirology; 2011 Apr; 16(3):430-8. PubMed ID: 21362105
[TBL] [Abstract][Full Text] [Related]
42. Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.
Klebe S; Mahar A; Henderson DW; Roggli VL
Mod Pathol; 2008 Sep; 21(9):1084-94. PubMed ID: 18587319
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of Aquaporin-1 in lung adenocarcinomas and pleural mesotheliomas.
López-Campos JL; Sánchez Silva R; Gómez Izquierdo L; Márquez E; Ortega Ruiz F; Cejudo P; Barrot Cortés E; Toledo Aral JJ; Echevarría M
Histol Histopathol; 2011 Apr; 26(4):451-9. PubMed ID: 21360438
[TBL] [Abstract][Full Text] [Related]
44. Neurotensin expression and outcome of malignant pleural mesothelioma.
Alifano M; Loi M; Camilleri-Broet S; Dupouy S; Régnard JF; Forgez P
Biochimie; 2010 Feb; 92(2):164-70. PubMed ID: 19932148
[TBL] [Abstract][Full Text] [Related]
45. [Differential diagnosis of preneoplastic lesions of the pleura and of early mesothelioma: immunohistochemical and morphological findings].
Krismann M; Thattamparambil P; Simon F; Johnen G
Pathologe; 2006 Mar; 27(2):99-105. PubMed ID: 16435096
[TBL] [Abstract][Full Text] [Related]
46. [Diagnostic difficulties in pleural mesothelioma].
Dubaniewicz A; Siemińska A
Wiad Lek; 1992 Apr; 45(7-8):248-50. PubMed ID: 1462582
[TBL] [Abstract][Full Text] [Related]
47. Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion.
Tsuji S; Tsuura Y; Morohoshi T; Shinohara T; Oshita F; Yamada K; Kameda Y; Ohtsu T; Nakamura Y; Miyagi Y
Br J Cancer; 2010 Aug; 103(4):517-23. PubMed ID: 20628387
[TBL] [Abstract][Full Text] [Related]
48. Assessment of cell cycle state may facilitate the histopathological diagnosis of malignant mesothelioma.
Sington JD; Morris LS; Nicholson AG; Coleman N
Histopathology; 2003 May; 42(5):498-502. PubMed ID: 12713628
[TBL] [Abstract][Full Text] [Related]
49. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining.
Mangano WE; Cagle PT; Churg A; Vollmer RT; Roggli VL
Am J Clin Pathol; 1998 Aug; 110(2):191-9. PubMed ID: 9704618
[TBL] [Abstract][Full Text] [Related]
50. Antemortem diagnosis of equine mesothelioma by pleural biopsy.
Fry MM; Magdesian KG; Judy CE; Pusterla N; Vidal JD; Pesavento RA; Zinkl JG
Equine Vet J; 2003 Nov; 35(7):723-7. PubMed ID: 14649368
[No Abstract] [Full Text] [Related]
51. Nonmesothelial Spindle Cell Tumors of Pleura and Pericardium.
Li H; Husain AN; Moffat D; Klebe S
Surg Pathol Clin; 2024 Jun; 17(2):257-270. PubMed ID: 38692809
[TBL] [Abstract][Full Text] [Related]
52. Over-expression of tenascin-C in malignant pleural mesothelioma.
Kaarteenaho-Wiik R; Soini Y; Pöllänen R; Pääkkö P; Kinnula VL
Histopathology; 2003 Mar; 42(3):280-91. PubMed ID: 12605648
[TBL] [Abstract][Full Text] [Related]
53. Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.
De Rienzo A; Richards WG; Yeap BY; Coleman MH; Sugarbaker PE; Chirieac LR; Wang YE; Quackenbush J; Jensen RV; Bueno R
Clin Cancer Res; 2013 May; 19(9):2493-502. PubMed ID: 23493352
[TBL] [Abstract][Full Text] [Related]
54. Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.
Gee GV; Koestler DC; Christensen BC; Sugarbaker DJ; Ugolini D; Ivaldi GP; Resnick MB; Houseman EA; Kelsey KT; Marsit CJ
Int J Cancer; 2010 Dec; 127(12):2859-69. PubMed ID: 21351265
[TBL] [Abstract][Full Text] [Related]
55. New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment.
Ladanyi M; Zauderer MG; Krug LM; Ito T; McMillan R; Bott M; Giancotti F
Clin Cancer Res; 2012 Sep; 18(17):4485-90. PubMed ID: 22825583
[TBL] [Abstract][Full Text] [Related]
56. A 37-year-old man with a pleural mass.
Eichelberger L; Jones TD; Vance G; Saxena R
Arch Pathol Lab Med; 2005 Aug; 129(8):1063-4. PubMed ID: 16048404
[No Abstract] [Full Text] [Related]
57. Unusual clear cell variant of epithelioid mesothelioma.
Dessy E; Falleni M; Braidotti P; Del Curto B; Panigalli T; Pietra GG
Arch Pathol Lab Med; 2001 Dec; 125(12):1588-90. PubMed ID: 11735696
[TBL] [Abstract][Full Text] [Related]
58. Disseminated malignant solitary fibrous tumor of the pleura.
Zhang H; Lucas DR; Pass HI; Che M
Pathol Int; 2004 Feb; 54(2):111-5. PubMed ID: 14720142
[TBL] [Abstract][Full Text] [Related]
59. Granulocyte colony stimulating factor-producing diffuse malignant mesothelioma of pleura.
Ohbayashi H; Nosaka H; Hirose K; Yamase H; Yamaki K; Ito M
Intern Med; 1999 Aug; 38(8):668-70. PubMed ID: 10440505
[TBL] [Abstract][Full Text] [Related]
60. Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know.
Opitz I; Bueno R; Lim E; Pass H; Pastorino U; Boeri M; Rocco G;
Eur J Cardiothorac Surg; 2014 Oct; 46(4):602-6. PubMed ID: 24623168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
